Vanguard Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,084,002
| Closed | -$246M | – | 4470 |
|
|
2021
Q1 | $246M | Sell |
3,084,002
-227,906
| -7% | -$17.8M | 0.01% | 1465 |
|
|
2020
Q4 | $261M | Sell |
3,311,908
-59,773
| -2% | -$3.51M | 0.01% | 1305 |
|
|
2020
Q3 | $148M | Sell |
3,371,681
-126,303
| -4% | -$6.22M | ﹤0.01% | 1469 |
|
|
2020
Q2 | $155M | Buy |
3,497,984
+66,168
| +2% | +$2.47M | 0.01% | 1433 |
|
|
2020
Q1 | $123M | Buy |
3,431,816
+86,488
| +3% | +$4.92M | 0.01% | 1405 |
|
|
2019
Q4 | $237M | Buy |
3,345,328
+56,956
| +2% | +$4.13M | 0.01% | 1292 |
|
|
2019
Q3 | $246M | Buy |
3,288,372
+24,977
| +0.8% | +$2.12M | 0.01% | 1207 |
|
|
2019
Q2 | $263M | Sell |
3,263,395
-7,562
| -0.2% | -$532K | 0.01% | 1194 |
|
|
2019
Q1 | $219M | Buy |
3,270,957
+53,794
| +2% | +$4.07M | 0.01% | 1279 |
|
|
2018
Q4 | $240M | Buy |
3,217,163
+77,610
| +2% | +$6.41M | 0.01% | 1137 |
|
|
2018
Q3 | $289M | Buy |
3,139,553
+64,320
| +2% | +$6.13M | 0.01% | 1143 |
|
|
2018
Q2 | $302M | Sell |
3,075,233
-14,048
| -0.5% | -$1.57M | 0.01% | 1069 |
|
|
2018
Q1 | $344M | Sell |
3,089,281
-236,166
| -7% | -$26.5M | 0.02% | 945 |
|
|
2017
Q4 | $342M | Buy |
3,325,447
+44,358
| +1% | +$4.42M | 0.02% | 956 |
|
|
2017
Q3 | $309M | Buy |
3,281,089
+112,575
| +4% | +$8.89M | 0.01% | 984 |
|
|
2017
Q2 | $247M | Buy |
3,168,514
+116,843
| +4% | +$8.78M | 0.01% | 1087 |
|
|
2017
Q1 | $244M | Buy |
3,051,671
+117,042
| +4% | +$9.3M | 0.01% | 1079 |
|
|
2016
Q4 | $231M | Buy |
2,934,629
+98,217
| +3% | +$7.63M | 0.01% | 1081 |
|
|
2016
Q3 | $221M | Buy |
2,836,412
+73,499
| +3% | +$5.33M | 0.01% | 1045 |
|
|
2016
Q2 | $190M | Buy |
2,762,913
+84,162
| +3% | +$5.81M | 0.01% | 1088 |
|
|
2016
Q1 | $191M | Buy |
2,678,751
+83,665
| +3% | +$5.25M | 0.01% | 1052 |
|
|
2015
Q4 | $161M | Buy |
2,595,086
+65,743
| +3% | +$4.01M | 0.01% | 1141 |
|
|
2015
Q3 | $143M | Buy |
2,529,343
+44,682
| +2% | +$2.37M | 0.01% | 1192 |
|
|
2015
Q2 | $133M | Buy |
2,484,661
+68,401
| +3% | +$3.33M | 0.01% | 1341 |
|
|
2015
Q1 | $115M | Buy |
2,416,260
+120,731
| +5% | +$5.34M | 0.01% | 1402 |
|
|
2014
Q4 | $99.3M | Buy |
2,295,529
+13,392
| +0.6% | +$547K | 0.01% | 1423 |
|
|
2014
Q3 | $78.5M | Buy |
2,282,137
+13,907
| +0.6% | +$491K | 0.01% | 1526 |
|
|
2014
Q2 | $83.1M | Sell |
2,268,230
-5,831
| -0.3% | -$198K | 0.01% | 1527 |
|
|
2014
Q1 | $76.7M | Buy |
2,274,061
+90,092
| +4% | +$2.97M | 0.01% | 1535 |
|
|
2013
Q4 | $74.1M | Buy |
2,183,969
+131,880
| +6% | +$4.57M | 0.01% | 1519 |
|
|
2013
Q3 | $65.4M | Buy |
2,052,089
+55,355
| +3% | +$1.47M | 0.01% | 1536 |
|
|
2013
Q2 | $45.1M | Buy |
+1,996,734
| New | +$43.2M | ﹤0.01% | 1692 |
|
Vanguard Group's CMD Position: Q2 2021 in Review
Vanguard Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,084,002 shares — an estimated $246M sold.
Vanguard Group first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $344M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Vanguard Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Vanguard Group sold 3,084,002 Cantel Medical Corporation shares in Q2 2021, an estimated $246M.
- Vanguard Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Vanguard Group's Cantel Medical Corporation position peaked at $344M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Vanguard Group's 13F filing for Q2 2021, filed 13 Aug 2021.